Top Markets
Coin of the day
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
Rang in Aktien #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Aktienkurs
$0.09933121
Marktkapitalisierung
$29.15K
Veränderung (1 Tag)
0.57%
Veränderung (1 Jahr)
449.49%
Land
IE
Handel Ovoca Bio plc (OVB)

Kategorie

EPS für Ovoca Bio plc (OVB)
EPS zum June 2024 TTM: $-0.07
Laut den aktuellen Finanzberichten und dem Aktienkurs von Ovoca Bio plc beträgt das aktuelle EPS des Unternehmens (TTM) $-0.07. Am Ende des Jahres 2023 betrug das EPS $-0.08 eine Steigerung gegenüber dem EPS von 2022, das $-0.07 betrug.
EPS-Verlauf von Ovoca Bio plc von 2001 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $-0.07 -100.00%
2024 0.00 -100.00%
2023 $-0.08 1.90%
2022 $-0.07 -3.28%
2021 $-0.08 119.25%
2020 $-0.03 61.86%
2019 $-0.02 -35.24%
2018 $-0.03 492.86%
2017 $-0.01 -54.84%
2016 $-0.01 -57.97%
2015 $-0.03 -67.97%
2014 $-0.09 -60.61%
2013 $-0.23 595.83%
2012 $-0.03 -153.50%
2011 $0.06 -220.77%
2010 $-0.05 -257.10%
2009 $0.03 -124.09%
2008 $-0.14 646.74%
2007 $-0.02 -87.28%
2006 $-0.14 210.52%
2005 $-0.05 9.39%
2004 $-0.04 0.00%
2003 $-0.04 92.76%
2002 $-0.02 -23.26%
2001 $-0.03 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$3.62 -5,152.02%
DK
$15.47 -21,676.01%
US
$43.12 -60,239.47%
US
$9.62 -13,518.13%
BE
$38.32 -53,544.91%
NL